Adherence of Beta Thalssemia Patients to Oral Chelation Therapy
- Conditions
- Beta-Thalassemia
- Registration Number
- NCT06568926
- Lead Sponsor
- Sohag University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria:<br><br> 1. confirmed diagnosis of beta thalassemia major or intermedia,<br><br> 2. Age between 2-18 years,<br><br> 3. Receiving regular blood transfusions every 2-5 weeks<br><br> 4. Prescribed oral iron chelation therapy with deferasirox for at least 1 year prior to<br> enrollment.<br><br>Exclusion Criteria:<br><br> 1. Age less than 2 years and more than 18 years<br><br> 2. Any cause of blood transfusion other than beta Thalassemia<br><br> 3. Patients on deferoxamine
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method serum ferritin level in beta thalassemia patients adherent to oral chelation therapy
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.